Trinity Biotech Plc (TRIB)
0.61
+0.01
(+1.33%)
USD |
NASDAQ |
May 07, 14:12
Trinity Biotech SG&A Expense (TTM) : 21.49M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amarin Corp. Plc | 92.35M |
| Cellectis SA | 19.83M |
| Akari Therapeutics Plc | 9.294M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| NuCana Plc | 10.74M |